Cancer Channel
Related Channels

Irinotecan Brand Name

Irinotecan is prescribed alone or in combination with other medications to treat colon or rectal cancer that has spread to other areas of the body. It is given through an intravenous (IV) infusion by a healthcare provider every one to three weeks.
Brand-name irinotecan (sold under the name Camptosar®) is manufactured by Pharmacia & Upjohn Company, a division of Pfizer Inc. There are also generic versions of irinotecan available that are made by various companies, including Hospira, Inc., and Teva Parenteral.
The brand-name irinotecan products are available in the following strengths:
  • 40 mg per 2 mL single-use vials
  • 100 mg per 5 mL single-use vials
  • 300 mg per 15 mL single-use vials.
(For more information, click Irinotecan. This article describes other dosing guidelines, potential side effects, and general safety precautions.)
5 Easy Tips to Manage Visitors During Cancer Treatment
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.